Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Steven T. Laing"'
Autor:
Sivan Cohen, Shan Chung, Christoph Spiess, Victor Lundin, Eric Stefanich, Steven T. Laing, Vanessa Clark, Jochen Brumm, Ying Zhou, Catherine Huang, Joyce Guerrero, Srividya Myneni, Rajbharan Yadav, Ketevan Siradze, Kun Peng
Publikováno v:
mAbs, Vol 13, Iss 1 (2021)
Bispecific antibodies (bsAbs) recognize and bind two different targets or two epitopes of the same antigen, making them an attractive diagnostic and treatment modality. Compared to the production of conventional bivalent monospecific antibodies, bsAb
Externí odkaz:
https://doaj.org/article/94fdf7b855084e94b55121a2d490ecd9
Autor:
Steven T. Laing, Al Ivens, Victoria Butler, Sai P. Ravikumar, Roz Laing, Debra J. Woods, John S. Gilleard
Publikováno v:
PLoS ONE, Vol 7, Iss 8 (2012)
Externí odkaz:
https://doaj.org/article/c57ce51ebf7d4c44b96057eefbfa45d7
Autor:
Susan Crowell, Nardos Tassew, Roxanne Andaya, Robert F. Kelley, Mandy Kwong, Kelly M. Loyet, Steven T Laing, Aija Kusi, Yue Wang, Julia Gray, Devin Tesar
Publikováno v:
Toxicologic Pathology. 49:634-646
Fusion of biologic therapeutics to hyaluronic acid binding proteins, such as the link domain (LD) of Tumor necrosis factor (TNF)-Stimulated Gene-6 (TSG-6), is expected to increase vitreous residence time following intravitreal injection and provide f
Publikováno v:
Toxicol Pathol
Rhesus and cynomolgus macaques are the most frequently used nonhuman primate (NHP) species for biomedical research and toxicology studies of novel therapeutics. In recent years, there has been a shortage of laboratory macaques due to a variety of com
Autor:
Rick Adler, Famke Aeffner, Laura E. Armstrong, Dmitri Artemov, Adam D. Aulbach, Bindu M. Bennet, Eric A. Blomme, Brad Bolon, Christopher J. Bowman, Molly Boyle, Alys Bradley, Dino Bradley, Danielle Brown, Pierre R. Bushel, Ellen Cannady, Mark F. Cesta, Curtis Chan, Jennifer A. Chilton, Peter J.M. Clements, Torrie A. Crabbs, Myrtle A. Davis, Sandy Eldridge, Daniela Ennulat, Jeffrey Everitt, Isabel Figueroa, James D. Fikes, Thomas Forest, Catherine A. Foss, John R. Foster, Kathleen Gabrielson, Shayne C. Gad, Kapil Gadkar, Jinping Gan, David Garcia-Tapia, Frank J. Geoly, Wendy G. Halpern, Jerry F. Hardisty, Wanda M. Haschek, Kathleen Marie Heinz-Taheny, Kristi Helke, Lauren E. Himmel, Mark J. Hoenerhoff, Jennifer L. Ingram–Ross, Armando R. Irizarry Rovira, Evan B. Janovitz, Kishore Katyayan, Charlotte M. Keenan, Angela King-Herbert, Steven T. Laing, Lois D. Lehman-McKeeman, Na Li, Calvert Louden, Claire Lyons, Kevin McDorman, Elizabeth McInnes, Lyn Miller Wancket, Sheroy Minocherhomji, Sébastien Monette, James Morrison, Vasanthi Mowat, Sydney Mukaratirwa, Keith Nelson, Arun R. Pandiri, Tracey Papenfuss, Nita Patel, Daniel J. Patrick, Shari A. Price, Deepa B. Rao, James T. Raymond, Jennifer Rojko, Colin G. Rousseaux, Sara F. Santagostino, Aaron Sargeant, Christina Satterwhite, A. Eric Schultze, Vanessa Schumacher, Cheryl Scudamore, Keith R. Shockley, Bhanu P. Singh, David M. Stresser, Polina Sysa-Shah, Debra A. Tokarz, Terry Van Vleet, Matthew A. Wallig, Jin Wang, Cynthia J. Willson, Kristin Lewis Wilson, Christopher T. Winkelmann, Jeffrey C. Wolf, Charles Wood, Daniela Bumbaca Yadav, Mark Zarella
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3831ed61c4599a4d47034bfb7e19d99
https://doi.org/10.1016/b978-0-12-821044-4.01002-5
https://doi.org/10.1016/b978-0-12-821044-4.01002-5
Autor:
Kelly M. Loyet, Steven T Laing, Craig Blanchette, Nardos Tassew, Whitney Shatz, Chris Schuetz, Susan Crowell
Publikováno v:
Toxicologic pathology. 49(3)
One strategy employed to prolong the ocular half-life of large molecule therapeutics is via covalent attachment to a carrier, resulting in an increase in size thereby slowing their clearance from the eye. Rabbit antigen-binding fragment conjugated to
Autor:
Ying Zhou, Jochen Brumm, Steven T Laing, Victor Lundin, Rajbharan Yadav, Joyce Guerrero, Kun Peng, Catherine Huang, Sivan Cohen, Vanessa Clark, Shan Chung, Eric Stefanich, Srividya Myneni, Christoph Spiess, Ketevan Siradze
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Bispecific antibodies (bsAbs) recognize and bind two different targets or two epitopes of the same antigen, making them an attractive diagnostic and treatment modality. Compared to the production of conventional bivalent monospecific antibodies, bsAb
Autor:
Isabella de Jong, Steven T Laing, Florence Lorget, Jeffrey Aaronson, Chris Schuetz, Nardos Tassew
Publikováno v:
Toxicologic pathology. 49(3)
Development of intravitreal drugs presents several challenges due to the delicate ocular environment and volume constraints of what can be safely administered in the eye. Formulation development of intravitreally administered drugs may necessitate th
Autor:
Melissa Schutten, Brandon Latifi, Ola Saad, Steven T Laing, Shabkhaiz Masih, Jintang He, Isabel Figueroa, Katherine R. Kozak, Douglas D. Leipold, Randall C. Dere, M. Violet Lee, Brian R. Vuillemenot, Andrew Polson, Keyang Xu, Ben-Quan Shen, Montserrat Carrasco-Triguero, Luna Liu, Dian Su, Victor Yip, Bing Zheng, Amrita V. Kamath
Publikováno v:
mAbs
Few treatment options are available for acute myeloid leukemia (AML) patients. DCLL9718A is an antibody-drug conjugate that targets C-type lectin-like molecule-1 (CLL-1). This receptor is prevalent on monocytes, neutrophils, and AML blast cells, and